T3D Therapeutics announced it has been awarded a competitive $50,000 Company Inception Loan (CIL) from the North Carolina Biotechnology Center. The CIL Program is designed to help bridge the early-stage funding gap that many North Carolina biotechnology companies face. Through the CIL program, loans of up to $50,000 are available for biotechnology companies in North Carolina. This program supports non-scientific business inception and related activities that are critical to the early-stage start-up of a biotechnology company.
T3D Therapeutics is Awarded a Competitive Company Inception Loan from the North Carolina Biotechnology Center
Aug 15, 2013 | News | 0 comments